These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9139084)

  • 1. Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O.
    Nkengasong JN; Fransen K; Willems B; Karita E; Vingerhoets J; Kestens L; Colebunders R; Piot P; van der Groen G
    J Med Virol; 1997 Mar; 51(3):202-9. PubMed ID: 9139084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease.
    Nicastri E; Ercoli L; Sarmati L; Ventura L; Parisi SG; Ciapetti C; Montano M; Andreoni M
    J Hum Virol; 1998; 1(2):90-5. PubMed ID: 10195237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
    Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
    Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
    Llano A; Barretina J; Gutiérrez A; Blanco J; Cabrera C; Clotet B; Esté JA
    J Virol; 2001 Nov; 75(21):10319-25. PubMed ID: 11581400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
    Jolly PE
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1057-65. PubMed ID: 9449539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
    Notermans DW; Pakker NG; Hamann D; Foudraine NA; Kauffmann RH; Meenhorst PL; Goudsmit J; Roos MT; Schellekens PT; Miedema F; Danner SA
    J Infect Dis; 1999 Oct; 180(4):1050-6. PubMed ID: 10479130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
    Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model.
    Otten RA; Ellenberger DL; Adams DR; Fridlund CA; Jackson E; Pieniazek D; Rayfield MA
    J Infect Dis; 1999 Sep; 180(3):673-84. PubMed ID: 10438354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
    Kelly HR; Urbanski M; Burda S; Zhong P; Konings F; Nanfack J; Tongo M; Kinge T; Achkar J; Nyambi P
    Hum Antibodies; 2005; 14(3-4):89-99. PubMed ID: 16720979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of different HIV-1 phenotypic subpopulations through the natural history of the infection].
    Pérez Alvarez L; Verdejo J; González Lahoz J; Gurbindo D; Hernández-Sampelayo T; Moreno E; Azañedo M; Contreras G; Medrano L; Nájera R
    Med Clin (Barc); 1998 Apr; 110(12):441-5. PubMed ID: 9611711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative p24 antigenaemia for monitoring response to antiretroviral therapy in HIV-1 group O-infected patients.
    Machuca A; Gutiérrez M; Mur A; Soriano V
    Antivir Ther; 1998; 3(3):187-9. PubMed ID: 10682137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.